(Q46507411)

22 December 2017

title

CA-125 criteria for response evaluation in ovarian cancer (English)

1 reference

22 December 2017

1 reference

Sundar S

1

1 reference

22 December 2017

O'Byrne KJ

series ordinal

2

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

22 December 2017

published in

Gynecologic Oncology

1 reference

22 December 2017

volume

98

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

520-521

1 reference

22 December 2017

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

Should CA-125 response criteria be preferred to response evaluation criteria in solid tumors (RECIST) for prognostication during second-line chemotherapy of ovarian carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

Do CA125 response criteria overestimate tumour response in second-line treatment of epithelial ovarian carcinoma?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.07.021

10.1016/J.YGYNO.2005.07.021

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017